Regulus jumps after data update from early-stage trial for kidney disease therapy
Regulus Therapeutics (RGLS) stock soars after positive Phase 1b trial data for the company's lead asset, farabursen against a ...
All customer locations and favorite drugs in Schedule 1
Schedule 1 lets you rise through the street ranks, starting from a small-time weed peddler to a total Heisenberg-level kingpin. However, to earn enough dough means earning enough connections, and ...
Indiatimes20h
Low P/E Ratio Stocks
Spotlights stocks with lower Price-to-Earnings ratios, suggesting potentially undervalued companies or those with steady earnings. Filters stocks where Trailing Twelve Months (TTM) Price-to-Earnings ...